Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics

Papaluca T, Roberts SK, SI S, et al. Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics. Clin Infect Dis [Internet]. 2021;73(9):e3288-e3295. https://doi.org/10.1093/cid/ciaa1318

Publication Type:

Journal Article

Authors:

Papaluca, T; Roberts, SK; Strasser SI; et, al

Source:

Clin Infect Dis, Volume 73, Issue 9, p.e3288-e3295 (2021)

URL:

https://doi.org/10.1093/cid/ciaa1318

Keywords:

Cirrhosis, genotype 3, Hepatitis C, relapse, sofosbuvir/velpatasvir/voxilaprevir

Cited On:

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/32887983/

Export Citation:

RIS Format

Top